Duspatalin - a drug used to relieve spasms and eliminate pain in some pathologies of the gastrointestinal tract. Many parents are concerned about whether you can give Duspatalin children?
According to the instructions, the use of Duspatalin allowed in patients under the age of 12 years. This is due to the fact that the effects of drugs are not fully understood and there is insufficient information reported no adverse effects during therapy in young children.
The main component acting Duspatalin - mebeverin represents Myotropic antispasmodic, having double effect. It helps to remove the spasm, but it does not cause intestinal, ie no effect on peristalsis and does not affect cholinergic synapses. Whereby not cause dryness in the mouth, visual disturbances, cardiac arrhythmia, urine retention, as well as disorders of the digestive functions.
However, a child of 4 years Duspatalin appoint impossible because the digestive system of children at this age are not yet fully formed, and the drug can cause negative symptoms.
When the drug is used
Duspatalin taken for the symptomatic treatment of pain caused by:
- spasms of the digestive tract;
- diseases of the upper digestive pathways that cause dyskinesia bile duct;
- irritable bowel syndrome (irritable bowel syndrome);
- pain and discomfort associated with dysfunction of the abdominal cavity.
Limitations of the drug
Duspatalin not used for therapy in the presence of individual intolerance of its components.
Taking medication in pregnant patients and nursing mothers conducted with extreme caution and under strict supervision of a specialist.
Duspatalin children under 12 not assignedBecause it was not carried out a sufficient number of clinical trials to prove the drug is completely harmless effect on the body of young children.
Side effects
the use of a medical device is usually in the therapeutic dose is well tolerated by patients. But in rare cases may develop adverse symptoms of the immune system, which can be expressed as follows:
- redness of the skin;
- facial swelling, up to angioedema;
- exanthema.
Sometimes the use of the drug may cause dizziness.
If the patient during the treatment of the above reactions occur or any other discomfort, it is necessary to interrupt the reception Duspatalin and consult a doctor.
use Features
If you want to assign Duspatalin child at age 9, the tool is replaced by an effective counterpart. Because in this age of medicine is forbidden to use and its intake can cause negative effects.
The use of medication during pregnancy is carried out only in case of emergency, if the benefit to the patient exceeds the potential risk to the fetus.
Since the tool can cause dizziness, during therapy is not recommended for activities that require increased attention and control of movement means.
Overdose
When exceeding the maximum therapeutic doses may increase the activity of the central nervous system. In this case it is necessary to conduct gastric lavage, absorbent substances and further symptomatic therapy. There is no specific antidote.
For young children
The drug Duspatalin children 6 years of age is contraindicatedIn this age of the child may be given other antispasmodics, such as no-silos or Buscopan, to help remove the discomfort and pain in the abdomen.
The child is 5 years old as medicine is not assigned. Most often, young children up to the age of six are used for pain papaverine.
How to store the medication
Duspatalin necessary to keep at room temperature (no higher than 25 degrees) out of reach of children. The shelf life of the drug is 3 years after the end of the packaging must be disposed of.
conclusion
Duspatalin - drug exhibiting antispasmodic properties and be administered to children who have reached 12 years of age and adults. The drug is very good for pain relief due to abnormalities of the digestive tract organs.
On the question as to whether or not Duspatalin little child, will answer - not, as yet held insufficient number of studies that can confirm the absence of the negative impact on small patients. If necessary, medication can be replaced with an analog having identical indications and authorized for use in pediatrics.
sources:
Vidal: https://www.vidal.ru/drugs/duspatalin__33504
GRLS: https://grls.rosminzdrav.ru/Grls_View_v2.aspx? routingGuid = 55cd07f4-f26a-48af-a082-3bcea9f6d970 & t =
Found a bug? Select it and press Ctrl + Enter
